Furthermore, when we restricted the analysis to patients with osteopenia and osteoporosis, the relationship became stronger at the spine, supporting the conclusion that anti-PC IgM levels may be biomarkers of bone loss. The gene discussed is CD40LG; the disease is Osteopenia.